It’s Not East Being Green: The FDA’s Duties Under NEPA and ESA When Approving New Drugs and Biological Products
Harvard Environmental Law Review
Publication
August 5, 2024
Please visit Harvard Environmental Law Review to view this article.
Related Practices
YOU MIGHT ALSO LIKE
Bilzin Sumberg is pleased to announce that Real Estate Attorney Hannah Lidicker has been named a recipient of Connect CRE's tenth annual Women in Real Estate Awards.
Bilzin Sumberg is proud to share that Robert Turken, Senior Trial & Litigation Partner, and Scott Wagner, Trial & Litigation Practice Group Leader and Co-Head of the firm's Antitrust Practice, have been named to The 2027 Lawdragon 500 Leading Litigators in America.
Ryan J. Coyle participates in the roundtable discussion, SPPI Showcase: A Profession Under Pressure, during the International Bar Association's Annual Copenhagen Conference.
